Trace Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History
Trace Wealth Advisors, LLC
- $122 Billion
- Q2 2025
A detailed history of Trace Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Trace Wealth Advisors, LLC holds 7,343 shares of BMY stock, worth $327,057. This represents 0.28% of its overall portfolio holdings.
Number of Shares
7,343
Previous 7,343
-0.0%
Holding current value
$327,057
Previous $448 Million
24.1%
% of portfolio
0.28%
Previous 0.4%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,675Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.68 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.07 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.81 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.22 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.15 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $94.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...